Federal contract award / Jul 10, 2025

TDA Research, Inc.

$1.3M

DHA PHASE II SBIR CONTRACT FOR PSORALEN-UV-A INACTIVATION BASED HIGH-THROUGHPUT PATHOGEN INACTIVATION DEVICE

View award details ↗

Award details

Award number
HT942525C0029
Contract type
Definitive Contract
Awarding agency
Department of Defense
Subagency
Defense Health Agency
Funding agency
Department of Defense / Defense Health Agency
Period
Jul 11, 2025 to Nov 10, 2027
Place of performance
Golden, Colorado 80403 / United States
NAICS
541715 / Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
PSC
AN12 / Health R&D Services; Health Care Services; Applied Research
Recipient UEI
MK5ANJVWVZK7

Your defense tech briefing

Security verification will run before you submit.